COVID-19 | Centre orders 11 mn doses of Covishield

Each dose of the vaccine has been priced at ₹200 and with GST of ₹10 it would cost ₹210.

Updated - December 03, 2021 05:42 am IST - New Delhi

Vials of Covishield at the Serum Institute of India, Pune.

Vials of Covishield at the Serum Institute of India, Pune.

Prime Minister Narendra Modi on Monday announced that the State governments would not have to pay for vaccinating the priority group of three crore healthcare and frontline workers, stating that the Centre would bear the cost.

The announcement came as the Central government placed a purchase order with the Pune-based Serum Institute of India (SII) for 11 million doses of Oxford COVID-19 vaccine, Covishield, at a cost of ₹210 per dose (including GST).

Official sources said that the dispatch of vaccines is likely to start late on Monday.

HLL Lifecare Limited, a public sector undertaking, issued the supply order on behalf of the Health Ministry. The Health Ministry is also slated to sign a purchase order with Bharat Boitech for its vaccine, Covaxin. “Meetings for this are under way,” a source said.

No out-of-turn jabs

Addressing Chief Ministers via videoconference ahead of the vaccination roll-out scheduled for January 16, Mr. Modi also “stressed on ensuring that politicians don’t jump the queue, and take the vaccine when their turn comes”. The direction comes amid requests by some States to include MPs, MLAs and panchayat heads in the priority groups.

‘Matter of pride’

Lauding the constant coordination and communication between the Centre and the States, Mr. Modi said, “It’s a matter of pride that both the COVID-19 vaccines for which Emergency Use Authorisation has been given are made in India.”

“Both the approved vaccines are highly cost-effective in comparison to other vaccines from across the world,” Mr. Modi said, adding that India would have faced great difficulty if it would have had to depend on foreign vaccines.

The Prime Minister noted that India’s vast experience with vaccination would prove handy.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.